STOCK TITAN

908 Devices (MASS) CEO Knopp sells 149K shares, reports 541K held via trust

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

908 Devices Inc. President and CEO Kevin J. Knopp reported open-market sales of an aggregate 149,013 shares of common stock over August 10–12, 2026, at weighted average prices around $9.06–$10.16, in transactions made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2025. An additional 541,223 shares are reported as indirectly owned through The Kevin J. Knopp Irrevocable Trust of 2018, for which his brother-in-law, as trustee, has sole voting and dispositive control, while Knopp may be deemed the beneficial owner.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Knopp Kevin J.
Role President and CEO
Sold 149,013 shs ($1.48M)
Type Security Shares Price Value
Sale Common Stock F1, F5 2,747 $10.07 $28K
Sale Common Stock F1, F3 115,748 $9.83 $1.14M
Sale Common Stock F1, F4 30,170 $10.16 $307K
Sale Common Stock F1, F2 348 $9.06 $3K
holding Common Stock F6 -- -- --
Holdings After Transaction: Common Stock — 583,590 shares (Direct); Common Stock — 541,223 shares (Indirect, See footnote)
Footnotes (6)
  1. F1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025.
  2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.05 to $9.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.08 to $10.0745 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.08 to $10.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.05 to $10.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. F6. The shares are owned directly by The Kevin J. Knopp Irrevocable Trust of 2018. The reporting person's brother-in-law is the trustee of The Kevin J. Knopp Irrevocable Trust of 2018 and has sole voting and dispositive control with respect to all securities held by such trust. The reporting person may be deemed to be the beneficial owner of the securities held by The Kevin J. Knopp Irrevocable Trust of 2018.
Total shares sold 149,013 shares Aggregate common stock sales reported from August 10–12, 2026
August 10 weighted average price $9.06 per share Sale of 348 shares on August 10, 2026; trades ranged $9.05–$9.08
August 11 weighted average prices $9.83 and $10.16 per share Sales of 115,748 and 30,170 shares on August 11, 2026
August 12 weighted average price $10.07 per share Sale of 2,747 shares on August 12, 2026; trades ranged $10.05–$10.25
Indirect trust holdings 541,223 shares Shares held by The Kevin J. Knopp Irrevocable Trust of 2018 as of August 10, 2026
10b5-1 plan adoption date May 20, 2025 Date Kevin J. Knopp adopted the Rule 10b5-1 trading plan
Rule 10b5-1 trading plan regulatory
"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial owner regulatory
"The reporting person may be deemed to be the beneficial owner of the securities"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
irrevocable trust financial
"The shares are owned directly by The Kevin J. Knopp Irrevocable Trust of 2018"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
voting and dispositive control regulatory
"has sole voting and dispositive control with respect to all securities held"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did 908 Devices (MASS) CEO Kevin J. Knopp report in this Form 4?

Kevin J. Knopp reported sales of 149,013 shares of 908 Devices common stock in multiple open-market transactions between August 10–12, 2026, under a pre-arranged Rule 10b5-1 trading plan adopted on May 20, 2025.

How many 908 Devices (MASS) shares did the CEO sell and at what prices?

Knopp sold a total of 149,013 shares at weighted average prices of $9.06, $9.83, $10.16, and $10.07, with individual trades occurring within stated ranges from $9.05 up to $10.34 per share.

Were the 908 Devices (MASS) insider sales made under a Rule 10b5-1 plan?

Yes. The filing states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted by Kevin J. Knopp on May 20, 2025, indicating the sales followed a pre-arranged trading schedule.

What indirect holdings of 908 Devices (MASS) stock are reported for Kevin J. Knopp?

The filing reports 541,223 shares of common stock held indirectly through The Kevin J. Knopp Irrevocable Trust of 2018, for which his brother-in-law is trustee. Knopp may be deemed the beneficial owner of these securities.

Who controls voting and dispositive power over the trust shares of 908 Devices (MASS)?

The filing states that Knopp’s brother-in-law, as trustee of The Kevin J. Knopp Irrevocable Trust of 2018, has sole voting and dispositive control over all securities held by the trust, while Knopp may be deemed their beneficial owner.

How many separate sale transactions did the 908 Devices (MASS) CEO report?

Kevin J. Knopp reported four non-derivative sale transactions in common stock from August 10–12, 2026, plus one additional entry reflecting 541,223 shares held indirectly through The Kevin J. Knopp Irrevocable Trust of 2018.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Knopp Kevin J.

(Last)(First)(Middle)
C/O 908 DEVICES INC
44 3RD AVENUE

(Street)
BURLINGTON MASSACHUSETTS 01803

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
908 Devices Inc. [ MASS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/10/2026S(1)348D$9.06(2)732,255D
Common Stock08/11/2026S(1)115,748D$9.83(3)616,507D
Common Stock08/11/2026S(1)30,170D$10.16(4)586,337D
Common Stock08/12/2026S(1)2,747D$10.07(5)583,590D
Common Stock541,223ISee footnote(6)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.05 to $9.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.08 to $10.0745 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.08 to $10.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.05 to $10.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The shares are owned directly by The Kevin J. Knopp Irrevocable Trust of 2018. The reporting person's brother-in-law is the trustee of The Kevin J. Knopp Irrevocable Trust of 2018 and has sole voting and dispositive control with respect to all securities held by such trust. The reporting person may be deemed to be the beneficial owner of the securities held by The Kevin J. Knopp Irrevocable Trust of 2018.
/s/ Mark S. Levine, Attorney-in-Fact08/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)